rss
Postgrad Med J 2008;84:252-258 doi:10.1136/hrt.2005.066944
  • Review

Antithrombotic treatment in atrial fibrillation

  1. G Y H Lip,
  2. C J Boos
  1. Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK
  1. Professor Gregory Y H Lip, Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, UK; g.y.h.lip{at}bham.ac.uk
  • Accepted 14 August 2005

Abstract

Atrial fibrillation (AF) can significantly increase morbidity and mortality. It is gaining in clinical and economic importance, being the most commonly encountered tachyarrhythmia in clinical practice. Stroke is the most serious complication. Evidence from AF antithrombotic treatment trials is reviewed, risk stratification of patients with AF is discussed, and recommendations for anticoagulation are presented.

Footnotes

  • Web table 1 and additional references appear on the Heart website—http://www.heartjnl.com/supplemental

  • Competing interests: GL has received funding for research, educational symposia, consultancy and lecturing from different manufacturers of drugs used for the treatment of atrial fibrillation and thrombosis. He is Clinical Adviser to the Guideline Development Group writing the United Kingdom National Institute of Clinical Excellence (NICE) Guidelines on atrial fibrillation management (www.nice.org.uk).

  • This is a reprint of a paper that appeared in Heart, August 2006, volume 92, pages 117–82. Reprinted with kind permission of the authors and publisher.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.